|
|
|
|
Document Preview Convertible Subordinated Note |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Convertible Subordinated Note |
|||
|
Entities: |
||||
|
Date: |
2002 |
|||
|
Size: |
Preview shows 4KB of 18KB total |
|||
|
Price: |
$41 |
|||
|
ID: |
#281788 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
THE SECURITIES REPRESENTED BY THIS CONVERTIBLE SUBORDINATED NOTE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE LAWS OF ANY
STATE AND MAY NOT BE TRANSFERRED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND
APPLICABLE STATE LAWS OR (B) AN OPINION OF COUNSEL FOR THE PAYEE REASONABLY
ACCEPTABLE TO THE MAKE THAT SUCH REGISTRATION IS NOT REQUIRED.
CONVERTIBLE SUBORDINATED NOTE
$5,999,998.72 January 29, 2002
FOR VALUE RECEIVED, the undersigned KENDLE INTERNATIONAL INC., an Ohio
corporation (the "Maker") hereby promises to pay to the order of CLINICAL AND
PHARMACOLOGIC RESEARCH, INC., a West Virginia corporation (together with its
permitted transferees and assigns, "CPR" or the "Payee"), the principal sum of
Five Million Nine Hundred Ninety-Nine Thousand Nine Hundred Ninety-Eight and
72/100 Dollars ($5,999,998.72), plus interest at the rate specified below. The
unpaid principal balance outstanding from time to time shall bear interest prior
to the Maturity Date (as defined below) at an annual rate of interest equal to
the yield of a United States Treasury Note with a maturity of three (3) years.
The initial interest rate, which shall be in effect from the date hereof through
January 29, 2005, shall be 3.80% PER ANNUM. In the absence of a conversion of
this Convertible Subordinated Note ("Note") under subsections (a) or (c) below,
interest shall be paid in cash semi-annually in arrears on each June 30 and
December 31 during the term of this Note, with the first interest payment to be
made on June 30, 2002.
The Maker hereby agrees to pay the entire amount due hereunder,
including the entire principal and all accrued but unpaid interest, on or before
January 29, 2005 ("Maturity Date"). If this Note has not been converted into
shares of common stock, no par value per share, of the Maker on or before
January 29, 2005, the Maker shall have the option to extend the Maturity Date of
this Note for another three (3) years, to January 29, 2008 by providing to Payee
additional documentation as reasonably requested by Payee. The Maturity Date, as
so extended, is hereinafter referred to as the "Final Maturity Date." The
interest rate on this Note will, if the Maturity Date is extended, be reset on
January 29, 2005 at an annual rate of interest equal to the yield of a United
States Treasury Note with a maturity of three (3) years from January 29, 2005.
The Maker shall exercise its option to extend the Maturity Date of this Note not
less than ten (10) business days prior to the Maturity Date.
Interest hereon shall be calculated on the basis of a 360-day year
based on the actual number of days elapsed until all accrued and unpaid interest
is paid in full. All payments of principal and interest shall be payable in
lawful currency of the United States.
{PAGE}
-2-
If any required payment of principal and interest is not timely made
and an Event of Default (as defined below) occurs, the interest rate shall
thereafter be increased by three (3%) percent PER ANNUM ("Default Rate"). All
interest due and payable hereunder which is not paid when due for any reason
shall be cumulated and accrue interest at the Default Rate.
|
End of Preview |
Home Intelligence Services Subscriptions News About Us